Navigation Links
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Date:1/24/2008

n, (2) increase Keflex 750 sales, (3) retain marketing approval for its MOXATAG product, (4) successfully reduce costs, (5) reach profitability, (6) prove that the preliminary findings for its product candidates are valid, (7) receive required regulatory approvals, (8) successfully conduct clinical trials in a timely manner, (9) establish its competitive position for its products, (10) develop and commercialize products that are superior to existing or newly developed competitor products, (11) develop products without any defects, (12) have sufficient capital resources to fund its operations, (13) protect its intellectual property rights and patents, (14) implement its sales and marketing strategy, (15) successfully attract and retain collaborative partners, (16) successfully commercialize and gain market acceptance for its Keflex products, (17) successfully obtain sufficient manufactured quantities of its drug products at acceptable rates, and (18) retain its senior management and other personnel. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. MiddleBrook undertakes no obligation to update or revise the information in this announcement, whether as a result of new information, future events or circumstances or otherwise.


'/>"/>
SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
2. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
3. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
4. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
7. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
8. New Data Show Unacceptably Low Adult Immunization Rates and That Adults Unaware of Infectious Disease Threat
9. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
10. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... 18 Jeffrey B. Kindler , Chairman ... of the Pharmaceutical Research and Manufacturers of America (PhRMA) ... were sanofi-aventis Chief Executive Officer Christopher Viehbacher ... John C. Lechleiter , Ph.D., Chairman, President and ...
(Date:3/18/2010)... the general question of the chemical origin of life lies the question of handedness, or chirality ... — including DNA, RNA, polysaccharides and proteins — are chiral. This means there are mirror image ... mirror reflections. , ... ...
(Date:3/18/2010)... ChemImage, a world leader in chemical imaging products ... particle sizing (ISPST) study on a combination Metered Dose ... www.rddonline.com ).  This conference will take place from ... and will feature thought leaders discussing current biological ...
Breaking Medicine Technology:Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8Tracking Down the Mystery of Life's 'Handedness' 2Tracking Down the Mystery of Life's 'Handedness' 3Tracking Down the Mystery of Life's 'Handedness' 4Tracking Down the Mystery of Life's 'Handedness' 5Tracking Down the Mystery of Life's 'Handedness' 6ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development 2ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development 3Study reveals H1N1 unexpected weakness 11084 1Study reveals H1N1 unexpected weakness 11084 2Successful stem cell therapy for treatment of eye disease 11081 1Successful stem cell therapy for treatment of eye disease 11081 2Too Much Drinking Eating Tied to Breast Cancer Recurrence 63045 1Too Much Drinking Eating Tied to Breast Cancer Recurrence 63045 2Too Much Drinking Eating Tied to Breast Cancer Recurrence 63045 3
... RESPeRATE while highlighting interest in the ... YORK, June 16 European Society of,Hypertension -- Booth ... device,company publicly traded on the Tel-Aviv Stock Exchange (TASE: ... highlighting RESPeRATE,-- the only medical device cleared by the ...
... Partner for the Phase 3 Program, ... Inc. (OTC Bulletin Board: TDLP), a specialty,pharmaceutical ... the initiation of its Phase 3 clinical ... non-steroidal,anti-inflammatory drug ("NSAID") for pain. The Company ...
Other Medicine Technology:Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies 2Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies 3Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies 4Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain 2Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain 3Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain 4
(Date:3/21/2010)... , . March 21 Health care reform is on its way and here to stay – but the work toward building a health ... ... , ... ... ...
(Date:3/21/2010)... Dr. Charmaine Yoest : , ... , , ... ... ... "Today, Congress ignored the explicit wishes of the American people by voting to establish taxpayer-funded abortion. This reversal of long-standing ...
(Date:3/21/2010)... an increased risk of developing high grade prostate cancer, ... That is the conclusion of a new study published ... of the American Cancer Society. The study,s results suggest ... for prostate cancer, early screening may be warranted in ... children a man has have pointed to male fertility,s ...
(Date:3/21/2010)... $940 billion overhaul would give 32 million more ... 21 (HealthDay News) -- After a year of ... late Sunday night passed the landmark $940 billion ... coverage to 32 million uninsured Americans, prevent insurance ... medical conditions and cut the federal deficit by ...
(Date:3/21/2010)... Life Action: , ... , , ... ... ... expansion of abortion since Roe v. Wade is a tragedy for America.  We believe that Mr. Stupak,s choice to succumb to the intense pressure of the ...
Breaking Medicine News(10 mins):Health News:'A Small Step For Today. A Giant Step For Tomorrow' 2Health News:'A Small Step For Today. A Giant Step For Tomorrow' 3Health News:Pro-Life Leader Dr. Charmaine Yoest on House Passage of Health Care Legislation 2Health News:Infertility increases a man's risk of prostate cancer 2Health News:House Democrats Approve Health-Care Reform Bill 2Health News:House Democrats Approve Health-Care Reform Bill 3Health News:House Democrats Approve Health-Care Reform Bill 4
... 22nd Calf Born into the Ringling Bros.(R) Conservation and Breeding ... Barnum & Bailey Center for Elephant Conservation (R) ... Asian elephant -- marking the twenty-second birth in what has ... in the Western Hemisphere. Most importantly, this is the first ...
... recommendations and being at an increased risk of breast cancer, ... a childhood cancer do not undergo appropriate mammography screening, according ... JAMA . , Women treated with chest radiation for a ... at a young age. "The risk of breast cancer begins ...
... Senate Cancer Caucus Co-Chairs Dianne Feinstein (D-CA) ... Jan. 27 Just three ... Senators Dianne Feinstein (D-CA)and Sam Brownback(R-KS) reintroduced ... of 2009 , legislation authorizing a comprehensive, ...
... Hooper Holmes (Amex: HH ) today announced ... President, General Counsel and Corporate Secretary. He has ... Inc.Mr. Rosenblum has over 23 years of corporate legal ... securities, contract, consumer and other class actions, as well ...
... addressing chronic disease crisisWASHINGTON, Jan. 27 The ... President Obama and Congress to make health reform ... reform efforts. Topping its list of "Principles for ... realign incentives in the health care system to ...
... survival rates in older patients , , TUESDAY, Jan. 27 ... brain natriuretic peptide (BNP) to guide treatment for older ... clinical outcome in most cases in a Swiss study. ... of monitoring blood levels of BNP, a protein produced ...
Other Medicine News:Health News:Ringling Bros. and Barnum & Bailey(R) Proudly Announces Its First Elephant Calf Born From Artificial Insemination 2Health News:Ringling Bros. and Barnum & Bailey(R) Proudly Announces Its First Elephant Calf Born From Artificial Insemination 3Health News:Ringling Bros. and Barnum & Bailey(R) Proudly Announces Its First Elephant Calf Born From Artificial Insemination 4Health News:Ringling Bros. and Barnum & Bailey(R) Proudly Announces Its First Elephant Calf Born From Artificial Insemination 5Health News:Many women who survived childhood cancer do not undergo recommended breast cancer screening 2Health News:Lung Cancer Alliance Hails Early Introduction of Comprehensive Lung Cancer Research Legislation 2Health News:Lung Cancer Alliance Hails Early Introduction of Comprehensive Lung Cancer Research Legislation 3Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 2Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 3Health News:National Partnership Releases Principles for Meaningful Health Reform 2Health News:Monitoring Protein Didn't Improve Heart Failure Outcomes 2Health News:Monitoring Protein Didn't Improve Heart Failure Outcomes 3
Leroy scalp clips, sterile, disposable, plastic, infant size, ten clips/package....
... Caspar scalp clip system made ... box profile and external opening ... opening positions, 15 clips each ... sterile peel refill packages (2 ...
Raney scalp clips, nickel plate, vial of 12....
... instrumentation, capable of comminution, aspiration ... means of ultra-sonic energy. Allows ... and, in particular, parenchymatous organs, ... tissue-selection and non-traumatic preparation with ...
Medicine Products: